<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(9)</volume><submitter>Moraczewski J</submitter><funding>NIAID NIH HHS</funding><funding>AHRQ HHS</funding><funding>AAAAI Foundation</funding><funding>AHRQ</funding><funding>NHGRI NIH HHS</funding><funding>NIAMS NIH HHS</funding><journal>The journal of allergy and clinical immunology. In practice</journal><pagination>2522-2525.e1</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12606405</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Direct oral challenges safely reduce the burden of low-risk cephalosporin allergy labels.</pubmed_title><pmcid>PMC12606405</pmcid><funding_grant_id>U01 AI181927</funding_grant_id><funding_grant_id>R01 HS030234</funding_grant_id><funding_grant_id>U01 AI154659</funding_grant_id><funding_grant_id>R13 AR078623</funding_grant_id><funding_grant_id>R01 HG010863</funding_grant_id><funding_grant_id>K08 AI185260</funding_grant_id><funding_grant_id>K12 HS026395</funding_grant_id><funding_grant_id>UM1 AI109565</funding_grant_id><funding_grant_id>R01 AI152183</funding_grant_id><funding_grant_id>L30 AI186122</funding_grant_id><pubmed_authors>Lee R</pubmed_authors><pubmed_authors>Phillips EJ</pubmed_authors><pubmed_authors>Krantz MS</pubmed_authors><pubmed_authors>Stone CA</pubmed_authors><pubmed_authors>Koo G</pubmed_authors><pubmed_authors>Moraczewski J</pubmed_authors><pubmed_authors>Allocco C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Direct oral challenges safely reduce the burden of low-risk cephalosporin allergy labels.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-05T13:52:10.249Z</modification><creation>2026-05-17T03:13:02.968Z</creation></dates><accession>S-EPMC12606405</accession><cross_references><pubmed>40484351</pubmed><doi>10.1016/j.jaip.2025.05.054</doi></cross_references></HashMap>